More than 500 clinical AI algorithms have now been cleared by the FDA, with the majority just in the past couple years.

There are now more than 520 FDA-cleared AI algorithms and the majority are for radiology and cardiology, raising the question of who is liable if the AI gets something wrong.

Brent Savoie, MD, JD, vice chair for radiology informatics, section chief of cardiovascular imaging, Vanderbilt University, explains who will get sued when there is a misdiagnosis due to artificial intelligence (AI).

Signify Research shares the latest big trends in cardiovascular IT systems, including the role of EMR cardiology modules vs. third-party CVIS, structured reporting, integration into enterprise imaging and inclusion of ambulatory surgical centers. 

The FDA has cleared U.K.-based Adaptix to market a 3D X-ray system that, according to the company, images hands, feet and elbows “at a fraction of the radiation dose and per-study cost of traditional CT.”

The model augmented and significantly improved diagnostic performance for abdominal subspecialists as well as residents—a result researchers say has major clinical implications.

Has point-of-care ultrasound outpaced hospitals’ capacity to incorporate the technology without anointing any particular specialty its proper guardian? The case could be made.

A multidisciplinary center dedicated to early detection of cancer in ostensibly healthy individuals has demonstrated the soundness of its founding concept, cost-effectively catching cancers of many kinds before the onset of symptoms.